Allspring Global Investments
TAK icon

Allspring Global Investments’s Takeda Pharmaceutical TAK Stock Holding History

Allspring Global Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Buy
34,749
+5,805
+20% +$96.1K ﹤0.01% 1414
2026
Q1 		$542K Buy
28,944
+8,549
+42% +$150K ﹤0.01% 1364
2025
Q4 		$318K Sell
20,395
-935
-4% -$13.4K ﹤0.01% 1501
2025
Q3 		$308K Sell
21,330
-758
-3% -$11.3K ﹤0.01% 1477
2025
Q2 		$341K Buy
22,088
+715
+3% +$10.6K ﹤0.01% 1441
2025
Q1 		$319K Buy
21,373
+1,098
+5% +$15.4K ﹤0.01% 1566
2024
Q4 		$269K Buy
20,275
+2,516
+14% +$34.6K ﹤0.01% 1611
2024
Q3 		$253K Buy
17,759
+6,852
+63% +$97.2K ﹤0.01% 1633
2024
Q2 		$141K Buy
10,907
+3,143
+40% +$41.6K ﹤0.01% 1791
2024
Q1 		$108K Buy
+7,764
New +$113K ﹤0.01% 1828
2022
Q1 		– Sell
-54,619
Closed -$744K – 3058
2021
Q4 		$744K Buy
+54,619
New +$766K ﹤0.01% 2112

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Allspring Global Investments's TAK Position: Q2 2026 in Review

Allspring Global Investments increased its Takeda Pharmaceutical (TAK) stake by 20% in Q2 2026, buying an estimated $96.1K and bringing the position to 34,749 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Allspring Global Investments first reported a position in TAK in Q4 2021 and has held it in 11 quarters since. The position peaked at $744K in Q4 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Allspring Global Investments held 34,749 shares of Takeda Pharmaceutical worth $579K as of Q2 2026.
  • Allspring Global Investments bought 5,805 Takeda Pharmaceutical shares in Q2 2026, an estimated $96.1K.
  • Takeda Pharmaceutical made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1414 holding.
  • Allspring Global Investments first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 11 quarters since.
  • Allspring Global Investments's Takeda Pharmaceutical position peaked at $744K in Q4 2021.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.